AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32736891 — intervention group
Group type: EXPERIMENTAL
Intervention: Linagliptin 5mg added to background insulin therapy
Number of subjects: 164
Study 32736891 — intervention group
Group type: COMPARATOR
Intervention: Control group continued insulin therapy
Number of subjects: 164
Study 35344649 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceritinib 450 mg with food
Number of subjects: 198
Study 35344649 — intervention group
Group type: COMPARATOR
Intervention: Ceritinib 750 mg fasted
Number of subjects: 198
Study 34644322 — intervention group
Group type: EXPERIMENTAL
Intervention: Cochlear Implant (CI)
Number of subjects: 120
Study 34644322 — intervention group
Group type: COMPARATOR
Intervention: Bone Conduction Device (BCD)
Number of subjects: 120
Study 34644322 — intervention group
Group type: COMPARATOR
Intervention: Contralateral Routing of Sound hearing aids (CROS)
Number of subjects: 120
Study 34644322 — intervention group
Group type: COMPARATOR
Intervention: All treatment groups (CI, BCD, CROS)
Number of subjects: 120
Study 32742646 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapioca resistant maltodextrin (TRM) 50 g
Number of subjects: 16
Study 34671998 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiked-in estimator
Number of subjects: 0
Study 34671998 — intervention group
Group type: EXPERIMENTAL
Intervention: Convex combination estimator
Number of subjects: 0
Study 33573631 — intervention group
Group type: EXPERIMENTAL
Intervention: Online multimedia psychoeducational interventions
Number of subjects: 50
Study 33573631 — intervention group
Group type: COMPARATOR
Intervention: Telephone-based psychological counseling
Number of subjects: 50
Study 33266447 — intervention group
Group type: COMPARATOR
Intervention: Fortified milk enriched with ω‐3 polyunsaturated fatty acids (EPA, DHA), vitamins (D, E, C, B6, B9, B12), and trace elements (zinc, selenium) consumed daily for 12 weeks.
Number of subjects: 48
Study 33266447 — intervention group
Group type: COMPARATOR
Intervention: Fortified milk
Number of subjects: 48
Study 33266447 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 48
Study 35994324 — intervention group
Group type: EXPERIMENTAL
Intervention: Sociotechnical intervention with redesigned workflows and clinical decision support technology
Number of subjects: 369
Study 35994324 — intervention group
Group type: COMPARATOR
Intervention: Control arm (standard care)
Number of subjects: 369
Study 34967847 — intervention group
Group type: EXPERIMENTAL
Intervention: sVLPD (very low-protein diet supplemented with ketoanalogues)
Number of subjects: 223
Study 34967847 — intervention group
Group type: COMPARATOR
Intervention: LPD (standard low-protein diet)
Number of subjects: 223
Study 34967847 — intervention group
Group type: EXPERIMENTAL
Intervention: sVLPD
Number of subjects: 223
Study 34967847 — intervention group
Group type: COMPARATOR
Intervention: LPD
Number of subjects: 223
Study 32370806 — intervention group
Group type: EXPERIMENTAL
Intervention: Luseogliflozin
Number of subjects: 24
Study 32370806 — intervention group
Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 24
Study 34904798 — intervention group
Group type: EXPERIMENTAL
Intervention: Tisagenlecleucel
Number of subjects: 322
Study 34904798 — intervention group
Group type: COMPARATOR
Intervention: Standard-care (salvage chemotherapy and autologous HSCT)
Number of subjects: 322
Study 34904798 — intervention group
Group type: COMPARATOR
Intervention: Standard-care
Number of subjects: 322
Study 34099646 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib (5 mg twice daily)
Number of subjects: 30
Study 32902389 — intervention group
Group type: EXPERIMENTAL
Intervention: Keenoa app (Keenoa-participant)
Number of subjects: 102
Study 32902389 — intervention group
Group type: EXPERIMENTAL
Intervention: Keenoa app (Keenoa-dietitian)
Number of subjects: 102
Study 32902389 — intervention group
Group type: COMPARATOR
Intervention: 3-day food diary (3DFD)
Number of subjects: 102
Study 32902389 — intervention group
Group type: EXPERIMENTAL
Intervention: System Usability Scale
Number of subjects: 102
Study 34656144 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose PXT3003 (6/0.70/210 mg)
Number of subjects: 323
Study 34656144 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose PXT3003 (3/0.35/105 mg)
Number of subjects: 323
Study 34656144 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 323
Study 35694969 — intervention group
Group type: EXPERIMENTAL
Intervention: ETMC5 (five-sensor esophageal thermal monitoring catheter)
Number of subjects: 106
Study 35694969 — intervention group
Group type: COMPARATOR
Intervention: ETMC3 (three-sensor esophageal thermal monitoring catheter)
Number of subjects: 106
Study 34351066 — intervention group
Group type: EXPERIMENTAL
Intervention: Interportal capsulotomy
Number of subjects: 33
Study 34351066 — intervention group
Group type: EXPERIMENTAL
Intervention: Periportal capsulotomy
Number of subjects: 33
Study 34351066 — intervention group
Group type: EXPERIMENTAL
Intervention: VAS
Number of subjects: 33
Study 32574167 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning model using biosignals (electrocardiogram, electrodermal activity, respiration)
Number of subjects: 0
Study 32574167 — intervention group
Group type: EXPERIMENTAL
Intervention: Bagged Trees classifier
Number of subjects: 0
Study 34632854 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational HPV intervention
Number of subjects: 20
Study 32776199 — intervention group
Group type: EXPERIMENTAL
Intervention: Spherical coordinates as collective variables with enhanced sampling technique metadynamics
Number of subjects: 16
Study 35814782 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning LT4 intake (60 min before breakfast)
Number of subjects: 201
Study 35814782 — intervention group
Group type: COMPARATOR
Intervention: Bedtime LT4 intake (60 min after the last meal)
Number of subjects: 201
Study 35814782 — intervention group
Group type: EXPERIMENTAL
Intervention: Both morning and bedtime LT4 intake
Number of subjects: 201
Study 35124909 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-venous (IV) hydration with 0.9% Normal Saline before the procedure
Number of subjects: 42
Study 34129159 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose B (lactulose, n=24)
Number of subjects: 46
Study 34129159 — intervention group
Group type: COMPARATOR
Intervention: Lactulose A (placebo, n=22)
Number of subjects: 46
Study 33351302 — intervention group
Group type: EXPERIMENTAL
Intervention: Yishen Tongluo Recipe combined with minimally invasive surgery (YTR+MIS)
Number of subjects: 116
Study 33351302 — intervention group
Group type: COMPARATOR
Intervention: Yishen Tongluo Recipe (YTR)
Number of subjects: 116
Study 33351302 — intervention group
Group type: COMPARATOR
Intervention: Minimally invasive surgery (MIS)
Number of subjects: 116
Study 34902474 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-Coated Balloon (DCB)
Number of subjects: 87
Study 33386751 — intervention group
Group type: EXPERIMENTAL
Intervention: Children living in areas with a larger number of churches at baseline
Number of subjects: 639
Study 33386751 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents' involvement in school activities
Number of subjects: 639
Study 33386751 — intervention group
Group type: EXPERIMENTAL
Intervention: Low maternal education, poor parents' perception of oral health, non-use of dental services, low frequency of tooth brushing
Number of subjects: 639
Study 33181830 — intervention group
Group type: EXPERIMENTAL
Intervention: Total carotenoid intake
Number of subjects: 2452
Study 33181830 — intervention group
Group type: EXPERIMENTAL
Intervention: Lycopene intake
Number of subjects: 2452
Study 33181830 — intervention group
Group type: EXPERIMENTAL
Intervention: Lutein + zeaxanthin intake
Number of subjects: 2452
Study 33181830 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E intake
Number of subjects: 2452
Study 33181830 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C intake
Number of subjects: 2452
Study 35745229 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention with pre-discharge educational session and follow-up by telephone at 3, 6, and 12 months post-discharge
Number of subjects: 273
Study 35745229 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention
Number of subjects: 273
Study 35745229 — intervention group
Group type: COMPARATOR
Intervention: Control group (minimum intervention with educational leaflet, follow-up phone calls, and questionnaires)
Number of subjects: 273
Study 35745229 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 273
Study 33692375 — intervention group
Group type: EXPERIMENTAL
Intervention: AAT M358R variant
Number of subjects: 0
Study 33692375 — intervention group
Group type: EXPERIMENTAL
Intervention: AAT-RC (combination of CLEVE and PRSTE motifs)
Number of subjects: 0
Study 33692375 — intervention group
Group type: EXPERIMENTAL
Intervention: AAT-RC
Number of subjects: 0
Study 32921396 — intervention group
Group type: EXPERIMENTAL
Intervention: Nevirapine (NVP)
Number of subjects: 40
Study 32921396 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir (LPVr)
Number of subjects: 40
Study 32921396 — intervention group
Group type: EXPERIMENTAL
Intervention: Efavirenz (EFV)
Number of subjects: 40
Study 32921396 — intervention group
Group type: COMPARATOR
Intervention: Control (Artemether/lumefantrine)
Number of subjects: 40
Study 35285357 — intervention group
Group type: EXPERIMENTAL
Intervention: Resource Facilitation (RF)
Number of subjects: 211
Study 35285357 — intervention group
Group type: COMPARATOR
Intervention: Control (no Resource Facilitation)
Number of subjects: 211
Study 34226094 — intervention group
Group type: EXPERIMENTAL
Intervention: Education plus planning condition (n=74 couples)
Number of subjects: 264
Study 34226094 — intervention group
Group type: COMPARATOR
Intervention: Education control (n=58 couples)
Number of subjects: 264
Study 36182632 — intervention group
Group type: EXPERIMENTAL
Intervention: Munich Breathlessness Service (MBS)
Number of subjects: 183
Study 34280999 — intervention group
Group type: EXPERIMENTAL
Intervention: Calm music group (CMG: n = 28)
Number of subjects: 85
Study 34280999 — intervention group
Group type: EXPERIMENTAL
Intervention: Happy music group (HMG: n = 30)
Number of subjects: 85
Study 34280999 — intervention group
Group type: EXPERIMENTAL
Intervention: Sad music group (SMG: n = 27)
Number of subjects: 85
Study 34280999 — intervention group
Group type: EXPERIMENTAL
Intervention: Calm music and happy music
Number of subjects: 85
Study 34280999 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative mood states
Number of subjects: 85
Study 34987791 — intervention group
Group type: EXPERIMENTAL
Intervention: Total thyroidectomy using a harmonic scalpel (HS)
Number of subjects: 100
Study 34987791 — intervention group
Group type: COMPARATOR
Intervention: Total thyroidectomy using conventional technique
Number of subjects: 100
Study 32273252 — intervention group
Group type: EXPERIMENTAL
Intervention: DCMedsRec intervention by community pharmacists
Number of subjects: 977
Study 32273252 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 977
Study 33903855 — intervention group
Group type: EXPERIMENTAL
Intervention: Camostat mesilate 200 mg three times daily for 5 days
Number of subjects: 205
Study 33903855 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 205
Study 33903855 — intervention group
Group type: EXPERIMENTAL
Intervention: Camostat mesilate
Number of subjects: 205
Study 32338611 — intervention group
Group type: EXPERIMENTAL
Intervention: shield+curtain+drape group
Number of subjects: 614
Study 32338611 — intervention group
Group type: COMPARATOR
Intervention: shield group
Number of subjects: 614
Study 32338611 — intervention group
Group type: COMPARATOR
Intervention: shield+curtain group
Number of subjects: 614
Study 36442895 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavioral therapy
Number of subjects: 1523
Study 34562501 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone treatment with no activation (NA)
Number of subjects: 108
Study 34562501 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone treatment with manual dynamic activation (MDA)
Number of subjects: 108
Study 34562501 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone treatment with passive ultrasonic activation (PUA)
Number of subjects: 108
Study 34562501 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone treatment with sonic activation (SA)
Number of subjects: 108
Study 34562501 — intervention group
Group type: COMPARATOR
Intervention: No ozone treatment (control)
Number of subjects: 108
Study 33348794 — intervention group
Group type: EXPERIMENTAL
Intervention: Group physiotherapy activity and awareness intervention (PAAI)
Number of subjects: 101
Study 33348794 — intervention group
Group type: COMPARATOR
Intervention: Control group (waitlist)
Number of subjects: 101
Study 35219302 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine 40 ml (medium concentration group)
Number of subjects: 90
Study 35219302 — intervention group
Group type: COMPARATOR
Intervention: 0.4% ropivacaine 40 ml (low concentration group)
Number of subjects: 90
Study 35219302 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6% ropivacaine 40 ml (high concentration group)
Number of subjects: 90
Study 33360219 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentration camp/ghetto survivors
Number of subjects: 346
Study 33360219 — intervention group
Group type: EXPERIMENTAL
Intervention: Holocaust survivors not in concentration camps/ghettos
Number of subjects: 346
Study 33360219 — intervention group
Group type: COMPARATOR
Intervention: Non-survivors
Number of subjects: 346
Study 32636319 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabozantinib
Number of subjects: 0
Study 32636319 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35048610 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved Unet network
Number of subjects: 117
Study 35048610 — intervention group
Group type: COMPARATOR
Intervention: FCN‐8s network
Number of subjects: 117
Study 35048610 — intervention group
Group type: COMPARATOR
Intervention: Unet network (Base)
Number of subjects: 117
Study 35048610 — intervention group
Group type: COMPARATOR
Intervention: Unet++ network
Number of subjects: 117
Study 34730488 — intervention group
Group type: EXPERIMENTAL
Intervention: Limb remote ischemic preconditioning (RIPC)
Number of subjects: 50
Study 32720906 — intervention group
Group type: EXPERIMENTAL
Intervention: Primeiros Laços home visiting intervention delivered by trained nurses, starting during the first 16 weeks of pregnancy until the child reaches 24 months of age.
Number of subjects: 80
Study 32720906 — intervention group
Group type: EXPERIMENTAL
Intervention: Primeiros Laços home visiting intervention delivered by trained nurses.
Number of subjects: 80
Study 32720906 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (control group).
Number of subjects: 80
Study 34937393 — intervention group
Group type: EXPERIMENTAL
Intervention: Device scenarios with 30-day mortality risks ranging from 0% to 15% and in-hospital complication risks ranging from 0% to 40%
Number of subjects: 613
Study 34937393 — intervention group
Group type: COMPARATOR
Intervention: No-device scenario
Number of subjects: 613
Study 34842534 — intervention group
Group type: EXPERIMENTAL
Intervention: Baby Steps Wellbeing
Number of subjects: 388
Study 34842534 — intervention group
Group type: COMPARATOR
Intervention: Baby Care
Number of subjects: 388
Study 34669239 — intervention group
Group type: EXPERIMENTAL
Intervention: Couplelinks online intervention
Number of subjects: 75
Study 34669239 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 75
Study 32669232 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical music (CM)
Number of subjects: 90
Study 32669232 — intervention group
Group type: COMPARATOR
Intervention: Voice calling names (CN)
Number of subjects: 90
Study 33432155 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflective interview, observation of infant cues, and video interaction guidance (VIG)
Number of subjects: 80
Study 33432155 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 80
Study 33432155 — intervention group
Group type: EXPERIMENTAL
Intervention: VIG (for per-protocol analysis)
Number of subjects: 80
Study 32289714 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS (a‐tDCS) at 1 mA for 22 and 24 minutes
Number of subjects: 15
Study 32289714 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS (a‐tDCS) at 1 mA for 26, 28, and 30 minutes
Number of subjects: 15
Study 32289714 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of short‐interval intracortical inhibition (SICI), intracortical facilitation (ICF), and long interval facilitation (LIF) via paired‐pulse TMS protocols
Number of subjects: 15
Study 33231786 — intervention group
Group type: EXPERIMENTAL
Intervention: ICBIT (Internet-based guided self-help comprehensive behavioral intervention for tics)
Number of subjects: 41
Study 33231786 — intervention group
Group type: COMPARATOR
Intervention: Wait-list (WL) condition
Number of subjects: 41
Study 36058230 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate 5 mg/day for 24 h plus standard care
Number of subjects: 325
Study 36058230 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 325
Study 36058230 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate
Number of subjects: 325
Study 33648350 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil 100 mg daily for 14 days
Number of subjects: 80
Study 33648350 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone 4 mg daily for 14 days
Number of subjects: 80
Study 32074369 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 160
Study 32074369 — intervention group
Group type: COMPARATOR
Intervention: Other Analgesics (OA)
Number of subjects: 160
Study 32074369 — intervention group
Group type: COMPARATOR
Intervention: No Analgesics (NA)
Number of subjects: 160
Study 36084413 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen (30 mg or 75 mg per day)
Number of subjects: 104
Study 36084413 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 33534804 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic pheromone + insecticide
Number of subjects: 8
Study 33534804 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 8
Study 36273173 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 mg encapsulated Xanthohumol (XN) per day
Number of subjects: 32
Study 36273173 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 33757601 — intervention group
Group type: EXPERIMENTAL
Intervention: Priming to expect LED food by asking participants to choose a LED snack before the match.
Number of subjects: 0
Study 33757601 — intervention group
Group type: COMPARATOR
Intervention: Control group (not primed).
Number of subjects: 0
Study 35752571 — intervention group
Group type: EXPERIMENTAL
Intervention: TiNO-stents
Number of subjects: 82
Study 35752571 — intervention group
Group type: COMPARATOR
Intervention: EES
Number of subjects: 82
Study 35752571 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 82
Study 33644992 — intervention group
Group type: COMPARATOR
Intervention: Repository corticotropin injection (RCI) 80 U twice weekly during a 12-week open-label period, followed by either RCI or placebo for another 12 weeks.
Number of subjects: 0
Study 33644992 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32916983 — intervention group
Group type: EXPERIMENTAL
Intervention: App with alarms
Number of subjects: 132
Study 32916983 — intervention group
Group type: COMPARATOR
Intervention: App without alarms
Number of subjects: 132
Study 32916983 — intervention group
Group type: COMPARATOR
Intervention: Usual treatment
Number of subjects: 132
Study 33068178 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level light therapy (LLLT)
Number of subjects: 90
Study 33068178 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% minoxidil
Number of subjects: 90
Study 33068178 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (LLLT + 5% minoxidil)
Number of subjects: 90
Study 33068178 — intervention group
Group type: COMPARATOR
Intervention: Control (5% minoxidil)
Number of subjects: 90
Study 32903373 — intervention group
Group type: EXPERIMENTAL
Intervention: Standing desks (T1)
Number of subjects: 52
Study 32903373 — intervention group
Group type: COMPARATOR
Intervention: Standing desks (T2)
Number of subjects: 52
Study 33229283 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation exercises
Number of subjects: 104
Study 33229283 — intervention group
Group type: COMPARATOR
Intervention: Routine healthcare services
Number of subjects: 104
Study 33734035 — intervention group
Group type: EXPERIMENTAL
Intervention: Cereal bar containing 80.73 milligrams of soybean and flaxseed phytoestrogens for 90 days
Number of subjects: 48
Study 33734035 — intervention group
Group type: COMPARATOR
Intervention: Rice flakes biscuit (placebo)
Number of subjects: 48
Study 35666897 — intervention group
Group type: EXPERIMENTAL
Intervention: type One Training (TOTs) program
Number of subjects: 36
Study 35666897 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 36
Study 32592335 — intervention group
Group type: EXPERIMENTAL
Intervention: MMF 2% mucoadhesive applied on the lesion twice daily for 4 weeks
Number of subjects: 27
Study 32592335 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 27
Study 36099080 — intervention group
Group type: EXPERIMENTAL
Intervention: Informative talk by professional healthcare providers about the benefits of HPV vaccination.
Number of subjects: 225
Study 36099080 — intervention group
Group type: EXPERIMENTAL
Intervention: Informative talk supplemented with a 1200-word written information source about the HPV vaccine.
Number of subjects: 225
Study 36099080 — intervention group
Group type: EXPERIMENTAL
Intervention: Informative talk supplemented with video content.
Number of subjects: 225
Study 33225463 — intervention group
Group type: EXPERIMENTAL
Intervention: Wellness‐4‐2 personalized prenatal stress‐reduction intervention
Number of subjects: 0
Study 33225463 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 34523814 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ocular dosing of GLH8NDE at doses of 9, 18, 36 mg (Koreans), and 36 mg (Whites)
Number of subjects: 40
Study 34523814 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 37499590 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadi Shodhana Pranayama
Number of subjects: 100